Available Cornell Technologies
- Raspberry 'Crimson Treasure'
- Multiplex Diagnostic Test for Equine Herpes Virus Type 1
- Treatment of Cardiac Disorder with Nicotinamide Riboside
- Use of a single massively multiplex digital PCR assay for minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) patients
- Novel Annexin A2 Antibodies as Therapeutics for Diabetic Retinopathy and Proliferative Vitreoretinopathy
- Use of Tumor-derived Exomeres as a Novel Biomarker in Cancer Detection
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world. In support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Tweets by @Cornell_CTL
Like CTL on Facebook
Like CTL on Facebook for a timeline of updates about Cornell Startups and products based on licensed Cornell technologies.
Plant Varieties at Cornell
|
|